BEVERLY MOSHER: Open Payments
NPI 1134536394 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 16 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $762 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 3 | $70 |
| Corcept Therapeutics | 2 | $70 |
| Noctrix Health, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Korlym, JARDIANCE, MOUNJARO, Ozempic, Wegovy, NIDRA, SHINGRIX, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
